Home › Funds › Catalio Capital Management, LP › VNDA

Catalio Capital Management, LP position in VNDA

VANDA PHARMACEUTICALS INC · Health Care

Catalio Capital Management, LP reported holding 11,357 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$226K, representing 0.04% of its reported portfolio and ranking #46 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.

Latest position (Q3 2026)11.36K sh
Reported value held$226.46K
Portfolio Weight0.04%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's VNDA position evolved

Catalio Capital Management, LP first disclosed a stake in VNDA in Q3 2026 at 11,357 shares (US$226K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 11.36K $226.46K New

About VNDA and 13F data

VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in VNDA — the largest reported positions include ORBIMED ADVISORS LLC (US$482.7M), SR ONE CAPITAL MANAGEMENT, LP (US$198.1M), Bain Capital Life Sciences Investors, LLC (US$134.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VNDA

All VNDA fund holders →

FAQ

How long has Catalio Capital Management, LP held VNDA?

Catalio Capital Management, LP has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Catalio Capital Management, LP's current position in VNDA?

As of Q3 2026, Catalio Capital Management, LP holds 11.36K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $226.46K, representing 0.04% of its reported portfolio and ranking #46.

Has Catalio Capital Management, LP been buying or selling VNDA?

In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in VNDA.

Which other funds hold VNDA?

Other major institutional holders of VNDA include ORBIMED ADVISORS LLC, SR ONE CAPITAL MANAGEMENT, LP, Bain Capital Life Sciences Investors, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.